Novartis India Ltd — Updates, 10-05-2025: Company Update

Novartis India has announced a board meeting outcome approving the audited financial results for the quarter and financial year ended March 31, 2025. The board has proposed a final dividend of INR 25 per equity share (face value INR 5), subject to shareholder approval. Mr. Sanker Parameswaran has been re-appointed as a Non-Executive Independent Director for a second term of five years, pending shareholder approval via Postal Ballot. The company also appointed M K Saraf & Associates LLP as Secretarial Auditors for five years. The 77th Annual General Meeting will be held on July 31, 2025.